Ramy Farid

Ramy Farid currently serves on the Board of Directors at Vir Biotechnology, Inc. and has been President and CEO of Schrödinger, Inc. since January 2002, where additional roles have included Board Director, President, Senior Vice President, and Vice President of Scientific Development and Product Management. Farid holds board membership positions at Structure Therapeutics, Ajax Therapeutics, and previously with Oak Hill Bio and Nimbus Therapeutics. Educationally, Farid earned a Ph.D. in Chemistry from Caltech and a BS in Chemistry from the University of Rochester, with postdoctoral experience as an NIH Fellow at the University of Pennsylvania School of Medicine and prior academic involvement as an Assistant Professor of Chemistry at Rutgers University.